On September 17, 2014, the Pharma & Biopharma Outsourcing Association made its official debut in front of FDA at a public hearing to discuss the Generic Drug User Fee Amendments.
February 27
February 10
Guest Post: Implications of Pfizer Acquisition of Hospira for the CMO Industry
Initial thoughts on the latest M&A action to impact CMOs
February 4
Mr. Roth Goes To Washington (and Vegas, New York and Bordeaux)
It’s a busy season for the PBOA and its members
